Applied Imaging Corp. said Thursday it will collaborate on a cancer research study organized and funded by the European Union. San Jose-based Applied Imaging said it was one of three commercial partners accepted as a collaborator in the three-year biomarker study directed toward the detection and dissemination of tumor cells.
Silicon Valley/San Jose Business Journal
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
FDA Extends UDI Deadlines Another Two Years for Class I, Unclassified Devices
The FDA said the new compliance date is Sept. 24, 2020.
United Exchange Warned for Inaccurate Listing Information
The agency had previously pointed out the deficiency in a February letter to the company.
FDAnews Device Daily Bulletin
APPLIED IMAGING COLLABORATES ON EU CANCER STUDY
June 5, 2006
